B

BioMarin Pharmaceutical
D

BMRN

68.215
USD
-0.53
(-0.76%)
مغلق
حجم التداول
107,637
الربح لكل سهم
4
العائد الربحي
-
P/E
41
حجم السوق
13,012,785,422
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: BioMarin Pharmaceutical

القطاع: Healthcare
الصناعة: Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline oftreatments in development.